A 56-year-old woman was diagnosed with Lambert-Eaton myasthenic syndrome (LEMS) after having been earlier diagnosed with other autoimmune conditions,…
Articles by Andrea Lobo, PhD
An agreement between Catalyst Pharmaceuticals and Teva Pharmaceuticals has ended a U.S. patent litigation case that began when…
People with Lambert-Eaton myasthenic syndrome (LEMS) have a lower quality of life and a higher disease burden than do…
The U.S. Food and Drug Administration (FDA) has approved increasing from 80 to 100 mg the maximum recommended daily dose…
A man in his 60s who developed Lambert-Eaton myasthenic syndrome (LEMS) secondary to prostate cancer saw his neurological symptoms…
The National Organization for Rare Disorders (NORD) is now accepting applications from patient advocacy organizations — ones focused on…
Catalyst Pharmaceuticals is on track to submit an application requesting an increase to the maximum recommended daily dose of…
The National Organization for Rare Disorders (NORD) has selected nine new Rare Disease Centers of Excellence, bringing to…
A sponsorship deal that grants Chiesi Global Rare Diseases access to BioInnovation Labs (BioLabs)’ network of life sciences…
The Canadian government has committed to invest CA$1.5 billion (about $1.1 billion) over three years to improve access to medicines…